跳至主要内容
临床试验/ACTRN12614000269639
ACTRN12614000269639进行中(未招募)4 期

A single centre nested cohort study investigating the effect of using 0.9 % saline or Plasmalyte 148 as primary fluid therapy on gastrointestinal complications in mechanically ventilated patients with nasogastric enteral nutrition

Medical Research Institute of New Zealand0 个研究点目标入组 200 人开始时间: 2014年3月13日最近更新:

试验速览

阶段
4 期
状态
进行中(未招募)
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Adult patients > 18 years.
  • Patients who are expected to be mechanically ventilated for greater than 48 hours and receiving NG enteral nutrition.

排除标准

  • Patients who are <18 years in age.
  • Patients expected to require mechanical ventilation for less than 48 hours.
  • Patients mechanically ventilated and not receiving enteral nutrition.
  • Patients receiving duodenal or jejunal feeding.
  • Patients who are expected to require renal replacement therapy within six hours of ICU admission.
  • Patients who are usually on dialysis for end stage renal failure.
  • Patients who are admitted to the ICU solely for consideration of organ donation or for palliative care.
  • Patients previously enrolled in the SPLIT trial.

研究者

相似试验